Evidence for cervical cancer mortality with screening program in Taiwan, 1981-2010: Age-period-cohort model

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Su, Shih Yung ^a,b   Huang, Jing Yang ^a   Ho, Chien Chang ^c   Liaw, Yung Po ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Age period cohort model; Cervical cancer; Gynecologic oncology; Mortality; Screening program

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; EARLY DIAGNOSIS; FEMALE; HEALTH CARE QUALITY; HUMAN; MIDDLE AGED; MORTALITY; STATISTICAL MODEL; TAIWAN; TIME; UTERINE CERVIX TUMOR;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; MODELS, STATISTICAL; MORTALITY; PROGRAM EVALUATION; TAIWAN; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84871978665     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-13     Document Type: Article

References (32)

1. Prognostic value of histopathology and trends in cervical cancer: a SEER population study. Vinh-Hung V, Bourgain C, Vlastos G, Cserni G, De Ridder M, Storme G, Vlastos AT, BMC Cancer 2007 7 164 10.1186/1471-2407-7-164 17718897 (Pubitemid 47506056)
2. Aggressive characteristics of cervical cancer in young women in Taiwan. Lau HY, Juang CM, Chen YJ, Twu NF, Yen MS, Chao KC, Int J Gynaecol Obstet 2009 107 3 220 223 10.1016/j.ijgo.2009.07.029 19716131
3. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia). Taylor R, Morrell S, Mamoon H, Wain G, Ross J, Cancer Causes Control 2006 17 3 299 306 10.1007/s10552-005-0515-z 16489537 (Pubitemid 43261893)
4. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991. Sigurdsson K, Int J Cancer 1993 54 563 570 10.1002/ijc.2910540408 8514448 (Pubitemid 23188185)
5. Effect of cervical cancer screening in Scandinavia. Day NE, Obstet Gynecol 1984 63 5 714 718 6717876 (Pubitemid 14143930)
6. A screening programme for cervical cancer that worked. Hakama M, Louhivuori K, Cancer Surv 1988 7 3 403 416 3242792
7. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer. Nygard JF, Skare GB, Thoresen SO, J Med Screen 2002 9 2 86 91 10.1136/jms.9.2.86 12133929 (Pubitemid 34822870)
8. Cervical cancer screening in England. Patnick J, Eur J Cancer 2000 36 17 2205 2208 10.1016/S0959-8049(00)00310-5 11072205
9. Cervical cancer screening in France. Schaffer P, Sancho-Garnier H, Fender M, Dellenbach P, Carbillet JP, Monnet E, Gauthier GP, Garnier A, Eur J Cancer 2000 36 17 2215 2220 10.1016/S0959-8049(00)00312-9 11072207
10. The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Holzel D, Goldie SJ, Eur J Public Health 2006 16 2 185 192 16469759
11. State-level differences in breast and cervical cancer screening by disability status: United States, 2008. Armour BS, Thierry JM, Wolf LA, Womens Health Issues 2009 19 6 406 414 10.1016/j.whi.2009.08.006 19879454
12. Recent immigrants and the use of cervical cancer screening test in Canada. Latif E, J Immigr Minor Health 2010 12 1 1 17 10.1007/s10903-009-9237-8 19259816
13. Epidemiology of cervical cancer in Taiwan. Wang PD, Lin RS, Gynecol Oncol 1996 62 3 344 352 10.1006/gyno.1996.0247 8812531 (Pubitemid 26322424)
14. Age-period-cohort models for the Lexis diagram. Carstensen B, Stat Med 2007 26 15 3018 3045 10.1002/sim.2764 17177166 (Pubitemid 46939424)
15. Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Chen YY, You SL, Chen CA, Shih LY, Koong SL, Chao KY, Hsiao ML, Hsieh CY, Chen CJ, Br J Cancer 2009 101 1 174 177 10.1038/sj.bjc.6605139 19536091
16. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. Koong SL, Yen AM, Chen TH, J Med Screen 2006 13 Suppl 1 44 S47 17227642
17. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Chang JI, Ou CH, Wu KM, Chen CC, Cheng KC, Zhonghua Yi Xue Za Zhi (Taipei) 2002 65 9 430 434
18. Screening for cervical cancer among female physicians and their relatives in Taiwan: a population-based comparative study. Chen LS, Huang N, Tsay JH, Wang PJ, Chou YJ, Chou P, Lee CH, Prev Med 2007 44 6 531 535 10.1016/j.ypmed.2007.02.001 17467786 (Pubitemid 46817641)
19. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Louie KS, de Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Munoz N, Bosch FX, Br J Cancer 2009 100 7 1191 1197 10.1038/sj.bjc.6604974 19277042
20. Risk factors for cervical cancer in Colombia and Spain. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tormo MJ, Moreo P, Ascunce N, Gonzalez LC, et al. Int J Cancer 1992 52 5 750 758 10.1002/ijc.2910520514 1330934
21. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, et al. Br J Cancer 2001 84 9 1219 1226 10.1054/bjoc.2001.1779 11336474 (Pubitemid 32511340)
22. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX, Lancet 2002 359 9312 1093 1101 10.1016/S0140-6736(02)08151-5 11943256 (Pubitemid 34270732)
23. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Walter LC, Lewis CL, Barton MB, Am J Med 2005 118 10 1078 1086 10.1016/j.amjmed.2005.01.063 16194635 (Pubitemid 41362604)
24. Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB, Int J Cancer 2004 108 2 258 261 10.1002/ijc.11543 14639612 (Pubitemid 37541780)
25. Geriatric oncology: cervical cancer screening in elderly women. Lichtman SM, N Y State J Med 1991 91 4 147 149 2047029
26. Screening for cervical cancer in elderly women. Lewis LS, Lancet 1990 335 8685 357 1967796 (Pubitemid 20051303)
27. Cost effectiveness of cervical cancer screening for the elderly. Fahs MC, Mandelblatt J, Schechter C, Muller C, Ann Intern Med 1992 117 6 520 527 1503355
28. Cervical cancer mortality is increasing in Spanish women younger than 50. Llorca J, Rodriguez-Cundin P, Dierssen-Sotos T, Prieto-Salceda D, Cancer Lett 2006 240 1 36 40 10.1016/j.canlet.2005.08.021 16229942 (Pubitemid 44037173)
29. Trends in cervix cancer mortality. Cuzick J, Boyle P, Cancer Surv 1988 7 3 417 439 3242793
30. Cervical cancer. Beral V, Hermon C, Munoz N, Devesa SS, Cancer Surv 1994 19-20 265 285 7621457 (Pubitemid 24289389)
31. Cervical cancer mortality in young women in Europe: patterns and trends. Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C, Eur J Cancer 2000 36 17 2266 2271 14. Lu TH 10.1016/S0959-8049(00)00346-4 11072218
32. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Lee MC, Chou MC, Int J Epidemiol 2000 29 2 336 343 10.1093/ije/29.2.336 10817134